MedPath

TEVA-TEMAZEPAM

TEVA-TEMAZEPAM

Discontinued
DIN Number

02230095

Drug Class

Human

Market Date

Dec 10, 1996

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230095
AIG Number0114415002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD07 TEMAZEPAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEMAZEPAMActive
Strength: 15 MG
Monograph: TEMAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.